ELORZA Maria Eugenia
The role of the pharmacist in the determination of pharmacotheraphy costs:ischemic cardiopathy patients with smoking habits
NADIA VANINA RIPARI; MARIA ELENA VEGA; MARIA EUGENIA ELORZA; NEBEL SILVANA MOSCOSO; DANIEL SANTIAGO PALMA; NADIA BUDASSI
Pharmaceuticals Policy and Law
Lugar: Amsterdam; Año: 2010 vol. 12 p. 313 - 319
In the last decades the pharmacist has played a main role in the policies of costs containment in the health sector. The present study has been designed to assess this role in the costs containment of the pharmacological treatments of patients at a Coronary Care Unit (CCU) of a public hospital in Argentina,through an analitic and retrospective study.It has been observed that the pharmacist could determine in all the service a saving of $ 3,393.03 buying the prescriptive drugs at minimum prices during the analized period. However, it has been proved that there are costs which the pharmacist cannot modify, as in the case of certain risk factors that may increase the pharmacological costs in the treatment of a pathology. This cost variation has been proved in ischemic cardiopathy patients with smoking habits.